Valuation: Southern Acids (M)

Market Cap 411M 101M 91.09M 84.26M 76.02M 143M 9.48B 148M 1.01B 401M 5.06B 377M 369M 16.07B P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value -15.66M -3.83M -3.47M -3.21M -2.9M -5.46M -361M -5.65M -38.59M -15.3M -193M -14.38M -14.08M -613M EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.2%
Yield 2025
1.64%
Yield 2026 1.65%
11-13 Southern Acids (M) Berhad Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 CI
10-19 Southern Acids (M) Berhad Reports Group Production Results for the Month of September 2026 CI
10-01 Southern Acids (M) Berhad Reassigns Lee Weng Hoong as Principal Officer, Effective October 1, 2026 CI
09-08 Southern Acids (M) Berhad Reports Group Production Results for the Month of August 2026 CI
08-28 Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Non Independent and Non Executive Director, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Appointment of Dato' Sri Dr Low Kok Thye as Acting Chairman, Effective August 28, 2026 CI
08-26 Southern Acids (M) Berhad Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
08-13 Southern Acids (M) Berhad Reports Group Production Results for the Month of July 2026 CI
08-05 Southern Acids (M) Berhad Announces Redesignation of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie from Independent Director to Non-Independent Director, Effective August 5, 2026 CI
07-27 Southern Acids (M) Berhad Announces Single Tier Final Dividend on Ordinary Share for Financial Year Ending March 31, 2027, Payable on 11 November 2026 CI
07-14 Southern Acids (M) Berhad Reports Group Production Results for the Month of June 2026 CI
1 day-0.33%
Current month-0.33%
1 month-1.96%
3 months-0.33%
6 months-6.25%
Current year-5.66%
1 month 3
Extreme 3
3.11
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.5
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 15/07/2015
Chief Tech/Sci/R&D Officer 38 16/07/2014
Corporate Secretary - 27/03/2023
Director TitleAgeSince
Director/Board Member 66 10/08/2005
Director/Board Member 59 20/03/2012
Chairman 47 28/08/2026
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%0.00%-5.96%-9.09% 101M
+0.67%+3.42%+9.91%+55.23% 48.41B
+2.76%+3.24%-8.08%+22.37% 38.62B
+2.24%+2.97%-4.10%-5.97% 17.27B
+2.54%-0.95%-16.80%+8.14% 12.03B
+2.16%+0.14%-28.28%-29.28% 5.28B
+2.48%+2.99%-3.72%+11.29% 4.98B
+1.75%+0.69%-6.15%+6.62% 4B
-0.47%+1.85%-25.88%+276.07% 3.9B
+1.06%-2.84%-9.80%+5.71% 3.55B
Average +1.49%+0.71%-9.89%+34.11% 14B
Weighted average by Cap. +1.74%+2.23%-3.14%+32.99%

Financials

2025 2026
Net sales 1.11B 271M 245M 227M 205M 386M 25.52B 399M 2.72B 1.08B 13.63B 1.02B 994M 43.27B 934M 228M 207M 191M 173M 326M 21.54B 337M 2.3B 912M 11.51B 857M 839M 36.52B
Net income 36.7M 8.98M 8.14M 7.53M 6.79M 12.8M 847M 13.25M 90.43M 35.86M 452M 33.7M 32.99M 1.44B 37.38M 9.15M 8.29M 7.67M 6.92M 13.03M 862M 13.49M 92.09M 36.52M 461M 34.32M 33.6M 1.46B
Net Debt -367M -89.77M -81.35M -75.25M -67.89M -128M -8.46B -132M -904M -358M -4.52B -337M -330M -14.35B -426M -104M -94.57M -87.47M -78.92M -149M -9.84B -154M -1.05B -417M -5.26B -392M -383M -16.68B
Projected Income Statement - Annual - Southern Acids (M)
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. 5134 Stock